Cefazolin and Toxic skin eruption - a phase IV clinical study of FDA data

Summary:

Toxic skin eruption is reported as a side effect among people who take Cefazolin (cefazolin sodium), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Pantoprazole, and have Staphylococcal infection.

The phase IV clinical study analyzes which people have Toxic skin eruption when taking Cefazolin. It is created by eHealthMe based on reports of 15,127 people who have side effects when taking Cefazolin from the FDA, and is updated regularly.

What is Cefazolin?

Cefazolin has active ingredients of cefazolin sodium. It is often used in infection. eHealthMe is studying from 15,157 Cefazolin users. Check the latest studies of Cefazolin.

What is Toxic skin eruption?

Toxic skin eruption (skin breakdown due to toxic substance) is found to be associated with 638 drugs and 1,064 conditions by eHealthMe. Check the latest studies of Toxic skin eruption.

On Jul, 09, 2026

15,127 people reported to have side effects when taking Cefazolin.
Among them, 47 people (0.31%) have Toxic skin eruption.

Could Cefazolin cause Toxic skin eruption?

Among these 47 people:

How long have people been on Cefazolin when they have Toxic skin eruption? *

What is the gender of people who have Toxic skin eruption when taking Cefazolin? *

female: 55.32 %
male: 44.68 %

What is the age of people who have Toxic skin eruption when taking Cefazolin? *

What are other drugs people take besides Cefazolin? *

What are other side effects people have besides Toxic skin eruption? *

Rashes (redness): 9 people, 19.15%
Hypersensitivity: 7 people, 14.89%
Itching: 5 people, 10.64%
Erythema Multiforme (a type of hypersensitivity reaction): 5 people, 10.64%
Rash Maculo-Papular (red area on the skin that is covered with small confluent bumps): 5 people, 10.64%
Blister (small pocket of fluid within the upper layers of the skin caused by forceful rubbing (friction), burning, freezing, chemical exposure): 4 people, 8.51%
Oedema (fluid collection in tissue): 3 people, 6.38%
Dermatitis Bullous (inflammation of the skin characterized by the presence of bullae which are filled with fluid): 3 people, 6.38%
Skin Hyperpigmentation (disorders affect the colour of your skin): 3 people, 6.38%
White Blood Cell Count Decreased: 2 people, 4.26%

What are the existing conditions these people have? *

Staphylococcal Infection (an infection with staphylococcus bacteria): 7 people, 14.89%
Staphylococcal Bacteraemia (a bacterial infection of blood): 5 people, 10.64%
Pseudomonas Infection (pseudomonas infection is caused by a bacterium, pseudomonas aeruginosa): 3 people, 6.38%
Cellulitis (infection under the skin): 3 people, 6.38%
Endocarditis (inflammation in heart muscle): 3 people, 6.38%
Superinfection: 2 people, 4.26%
Herpes Simplex (herpes simplex is a common viral infection): 2 people, 4.26%
Atypical Mycobacterial Infection (infections caused by several types of mycobacterium similar to the germ that causes tuberculosis): 2 people, 4.26%
Cerebral Toxoplasmosis (parasitic disease of brain caused by the protozoan toxoplasma gondii): 2 people, 4.26%
Chalazion (cyst in the eyelid): 2 people, 4.26%

* Approximation only. Some reports may have incomplete information.

Do you take Cefazolin and have Toxic skin eruption?

- Check whether Toxic skin eruption is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Cefazolin:

Cefazolin (15,157 reports)

Browse all side effects of Cefazolin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Toxic skin eruption:

Toxic skin eruption (638 drugs)

Browse all the conditions that are associated with Toxic skin eruption:

Toxic skin eruption (1,064 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on cefazolin sodium (the active ingredients of Cefazolin) and Cefazolin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.